Non-Coding RNAs in Cancer Liquid Biopsy: From Regulatory Networks to Functional Biomarkers for Precision Oncology
Genes · 23.07.2026 · 17 (8) · 847
DOI: 10.3390/genes17080847 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Genes, online erschienen am 23.07.2026. Verfasst von Salvatore Pernagallo und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Environmental and Prevention Sciences, University of Ferrara, 44121 Ferrara, Italy. Hauptthemen laut MEDLINE: Biomarkers, Tumor, Neoplasms, Precision Medicine, RNA, Untranslated. Die Arbeit nennt 168 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Liquid biopsy is now an established component of precision oncology, and its clinical implementation to date has been led by cell-free DNA (cfDNA) and circulating tumor DNA (ctDNA) assays. These assays report genomic alterations, yet they may be limited by low tumor fraction, reduced shedding in early disease, and incomplete representation of dynamic tumor biology. Non-coding RNAs (ncRNAs), including microRNAs (miRNAs), long non-coding RNAs (lncRNAs), circular RNAs (circRNAs), and emerging small or poorly annotated RNA species, provide a complementary layer because they can reflect regulatory programs, tissue injury, immune modulation, metastatic communication, and therapeutic pressure. This review explores circulating and extracellular vesicle (EV)-associated ncRNAs as functional readouts in cancer liquid biopsy. We discuss their biological origin, carrier state, biofluid context, clinical applications, analytical technologies, artificial intelligence (AI)-assisted integration, standardization barriers, and regulatory requirements. The technology discussion considers sequencing, targeted amplification, and emerging direct or polymerase chain reaction (PCR)-free strategies as complementary translational routes for reliable ncRNA measurement. We propose that ncRNAs should not be viewed as alternatives to ctDNA, but as potential functional biomarkers that can link tumor genotype, regulatory state, and clinical phenotype within integrated multi-analyte precision oncology.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Environmental and Prevention Sciences, University of Ferrara, 44121 Ferrara, Italy.
- Department of Translational Medicine, University of Ferrara, 44121 Ferrara, Italy.
ORCID-Profile: Salvatore Pernagallo, Veronica Tisato, Donato Gemmati
Zitieren
APA
Pernagallo, S., Tisato, V., & Gemmati, D. (2026). Non-Coding RNAs in Cancer Liquid Biopsy: From Regulatory Networks to Functional Biomarkers for Precision Oncology. Genes, 17(8), 847. https://doi.org/10.3390/genes17080847
Vancouver
Pernagallo S, Tisato V, Gemmati D. Non-Coding RNAs in Cancer Liquid Biopsy: From Regulatory Networks to Functional Biomarkers for Precision Oncology. Genes. 2026;17(8):847. doi:10.3390/genes17080847
BibTeX
@article{Pernagallo2026,
author = {Pernagallo, Salvatore and Tisato, Veronica and Gemmati, Donato},
title = {Non-Coding RNAs in Cancer Liquid Biopsy: From Regulatory Networks to Functional Biomarkers for Precision Oncology},
journal = {Genes},
year = {2026},
volume = {17},
number = {8},
pages = {847},
doi = {10.3390/genes17080847}
}
EUVIMED